Experts Discuss Sequencing of Therapies for Relapsed/Refractory Multiple Myeloma

Decera Clinical Education Oncology Podcast · Sep 30, 2026 · 28m

Listen to Jesus G. Berdeja, MD, and Ajai Chari, MD, as they discuss sequencing of antibody–drug conjugates (ADCs), bispecific antibodies, CAR T-cell therapy, and other novel treatment modalities for patients with relapsed/refractory multiple myeloma.

Presenters:

Jesus G. Berdeja, MD

Director of Myeloma Research

Greco-Hainsworth Centers for Research

Partner

Tennessee Oncology

Nashville, Tennessee

Ajai Chari, MD

Professor of Clinical Medicine

Director of Multiple Myeloma Program

UCSF Helen Diller Family Comprehensive Cancer Center

University of California, San Francisco (UCSF) Medical Center…